The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of ----10(b) and 20(a) of the Securities ...

Medpace (MEDP) closed at $501.23 in the latest trading session, marking a +1.56% move from the prior day. This change outpaced the S&P 500's 1.02% gain on the day. Meanwhile, the Dow experienced a ...

Medpace Holdings Inc. misled the public by overstating projected demand for its clinical trial services, an investor alleges ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for ...

Medpace Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

In the closing of the recent trading day, Medpace (MEDP) stood at $508.52, denoting a +2.52% move from the preceding trading day.

Medpace has a strong financial position with high profit margins and low debt, and it has grown at a fast rate in the last five years. The company expects headwinds in 2025 in that it foresees that ...

Medpace Holdings (MEDP) has drawn attention after recent share price swings, with a 1-day return of about a 1.6% decline and a past 3-month return of roughly a 17% decline. See our latest analysis for ...

Discover what drives dramatic price swings in stocks like Medpace (NASDAQ: MEDP) and how market mechanics, not just news, can shape outcomes. Watch the video below to learn how investors can navigate ...

For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value ...

Add Yahoo as a preferred source to see more of our stories on Google. Two new dining options are coming to Medpace's Madisonville campus. The city of Cincinnati greenlit development for outdoor dining ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” ...